It's getting a bit repetitive. The call (battle cry) for repeal, waivers or at least a delay in health reform is everywhere in the health insurance industry. It's also coming from retailers, pharmacies and manufacturers.
Last week, opposition resonated from a number of groups that want Congress to change the new federal law, effective Jan. 1, and allow over-the-counter drugs to be purchased with money from flexible spending accounts.
These groups are asking Congress — during its lame duck session — to push back the law's start date two years, if it won't repeal altogether.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
